Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Novartis to acquire ocular gene therapy company Gyroscope Therapeutics Novartis has agreed to acquire Gyroscope Therapeutics, a UK-based ocular gene therapy company, in a deal worth up… bySrinathJanuary 3, 2022
